Skip to main content
. 2020 Jun 22;79(10):1362–1369. doi: 10.1136/annrheumdis-2020-217419

Figure 2.

Figure 2

Disease activity as measured by PGA over time. Percentages of patients were calculated using as denominator the total number of patients evaluated at each time point (n), for the groups of patients who received cumulative doses <2700 mg (n=44) and ≥2700 mg (n=16) during Epoch 4. PGA, physician’s global assessment.